Neutral impactOrders & Deals

Neuland Laboratories Q2: Profit falls 47%, revenue declines 12.5%; margins contract

CNBC-TV18 2 hrs ago·3 Nov 2026, 11:24 am

Neuland Laboratories reported a 46.7% year-on-year decline in consolidated profit to ₹51.6 crore, while EBITDA margin contracted to 21.7% from 30.2% a year ago. The company cited a dip in quarterly performance but retained its FY27 growth expectations.

Affected stocks

Neutral1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Neuland Laboratories (NEULANDLAB).
  • Category: Orders & Deals.

Why it matters

A routine update for Neuland Laboratories. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at CNBC-TV18.

More Stocks news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.